First-in-human clinical trial evaluates safety of stem cell
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
The first-in-human clinical trials to evaluate the safety of stem cell treatments for spinal injury have been expanded to include four new participants.

First started in 2014, the phase I study is working to assess the toxicity of neural stem cell transplantation for individuals with chronic cervical spinal cord injuries. This is a collaborative project undertaken by the UC San Diego School of Medicine, the Sanford Stem Cell Clinical Center at UC San Diego Health, and a Maryland-based biotechnology company called Neuralstem.

“The ultimate goal is development of an effective treatment for paralyzing spinal cord injuries,” Joseph Ciacci, principal investigator and neurosurgeon at UC San Diego Health, said. “The immediate goal is to determine whether injecting these neural stem cells into the spines of patients with injuries is safe.”

Researchers have confirmed the eligibility of four new participants, who have injuries to the C5-C7 vertebrae. Participants will first undergo surgical intervention with six stem cell injections, followed by an intensive 60-month follow-up period. The trial involves a line of human stem cells that have already received approval for use in human trials from the U.S. Food and Drug Administration......

https://lifesciencedaily.com/stories/20916-first-human-clinical-trial-evaluates-safety-stem-cell-transplant-procedure-spinal-injury-patients/
Preview
Dr. V●●●●●v V●●a and 3 others like this
Like
Comment
Share